GRP logo
A Checklist For Retrospective Database Studies

A Checklist for Retrospective Database Studies – Report of the ISPOR Task Force on Retrospective Databases

The citation for this report is:
Motheral B, Brooks J, Clark MA, et al. A checklist for retroactive database studies – Report of the ISPOR Task Force on Retrospective Databases. Value in Health 2003;6:90-7

Task Force Chair
Brenda Motheral MBA, PhD, Vice President, Express Scripts, Maryland Heights, MO, USA

Leadership Group
John Brooks PhD, Assistant Professor, College of Pharmacy, University of Iowa, Iowa, City, IA, USA
Mary Ann Clark MHA, Manager Outcomes Analytic, Boston Scientific Corporation, Natick, MA, USA
William Crown PhD, Vice President, Outcomes Research, The Medstat Group, Cambridge, MA, USA
Peter Davey MD, FRCP, head of Pharmacoeconomics, Department of Clinical Pharmacology, University of Dundee, Dundee, UK
Dave Hutchins MBA, MHSA, Researcher, Advanced PCS Health Systems, Inc., Scottsdale, AZ, USA
Bradley C. Martin PharmD, PhD, Associate Professor, College of Pharmacy, University of Georgia, Athens, GA, USA
Paul Stang PhD, Vice President, Galt Associates, Inc., Blue Bell, PA, USA

Review Group
Frederick Berggen, PhD, Scientific Advisor, AstraZeneca R&D, Lund Sweden
James Chan, PharmD, Pharmacy Operator, Kaiser Foundation, Oakland, CA USA
Suellen Curkendall, PhD, Director of Research, The Degge Group, Arlington, VA, USA
William Edell, PhD, Plano, TX, USA
Shelah Leader, PhD, Director, Medimmune, Gaithersburg, MD, USA
Marianne McCollum, RPH, PhD, Assistant Professor, University of Colorado, Denver, CO, USA
Newell McElwee, PharmD, MSPH, Senior Director, Pfizer, Inc., New York, NY, USA
John Walt, MBA, Manager, Allergan, Inc., Irvine, CA, USA


ISPOR Good Practices For Outcomes Research Index